24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
InMode
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
09:32
“Suffocating innovation”: Intel’s new CEO dismantles hierarchy
18:17
“Our goal is to build a generational company,” says Deel CEO amid espionage case
16:36
Tenable names co-CEOs to lead after Amit Yoran’s death
16:35
AU10TIX appoints Yair Tal as CEO
More stories
Buzz
Most popular
Daily
Weekly
1
“Suffocating innovation”: Intel’s new CEO dismantles hierarchy
2
Layoffs loom as Intel’s new CEO moves to fix slow decision-making and chip production
3
Intel’s breakup begins with sale of $8.75B-valued Altera to private equity giant Silver Lake
4
Tenable names co-CEOs to lead after Amit Yoran’s death
5
Check Point's X-Factor: Can Nadav Zafrir wake the sleeping giant?
More news
InMode
5 stories about InMode
Medical Aesthetic Company InMode in Talks for Secondary Offering
23.12.19
|
Golan Hazani
The Israel-based company listed on Nasdaq in August at a $450 million company valuation but has since reached a $1.3 billion market capitalization
Dreams of Eternal Youth Boost InMode’s Valuation
04.11.19
|
Sophie Shulman
The medical aesthetic devices manufacturer doubled its market capitalization since its August IPO on Nasdaq, passing the $1 billion mark this past weekend
Medical Aesthetic Device Manufacturer InMode Raises $70 Million on Nasdaq IPO
11.08.19
|
Golan Hazani
InMode priced its shares at $14, the lower end of its previously suggested range, giving the company a pre-money valuation of $378 million
Medical Aesthetic Devices Manufacturer InMode Looking to Raise $75 Million on Nasdaq
14.07.19
|
CTech
In June, Calcalist reported that InMode is looking to list on Nasdaq according to a company valuation of $400 million to $500 million
Medical Aesthetic Devices Manufacturer InMode Gearing Up for Nasdaq IPO
03.06.19
|
Golan Hazani
InMode develops devices that use radio-frequency energy technology, capable of penetrating subdermal fat